New Regimen Boosts DLBCL Treatment: BTK Inhibitors, Rituximab, Lenalidomide
In a significant leap in treating newly diagnosed diffuse large B-cell lymphoma (DLBCL), researchers have unveiled promising results from a ...
In a significant leap in treating newly diagnosed diffuse large B-cell lymphoma (DLBCL), researchers have unveiled promising results from a ...
In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine